Balloon Tamponade Vs B-Lynch In Placenta Previa
Launched by CMH JHELUM · Nov 15, 2021
Trial Information
Current as of August 24, 2025
Completed
Keywords
ClinConnect Summary
After approval from hospital ethical committee, patients fulfilling the inclusion \& exclusion criteria were recruited after taking informed written consent for surgery. Patients were allocated to group A and B using computer generated random sample allocation.
In group A, balloon tamponade (using Foley catheter 28 Fr) was used intra-operatively to prevent post-partum hemorrhage. Post-operative blood loss within first 24 hours was estimated by measuring the amount of blood collected in Foley balloon tamponade bag, in milliliters.
In group B, B-lynch suture was used intra-operatively to pr...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Singleton pregnancy
- • 2. Late Third Trimester pregnancy (35+ weeks to 39 weeks)
- • 3. Placenta Previa confirmed by ultrasonography
- • 4. Elective Caesarean Section.
- Exclusion Criteria:
- • 1. Multiple gestation
- • 2. Placenta accreta Spectrum (accrete/increta/percreta)
- • 3. Bleeding diathesis
- • 4. Other Causes of Post-Partum Hemorrhage i.e. Uterine atony, Genital tract tears, Retained Products of Conception etc.
- • 5. Serious medical or surgical diseases.
About Cmh Jhelum
CMH Jhelum is a leading clinical research organization based in Jhelum, Pakistan, dedicated to advancing medical knowledge and improving patient care through rigorous clinical trials. With a commitment to high ethical standards and regulatory compliance, CMH Jhelum collaborates with healthcare professionals and research institutions to facilitate innovative studies across various therapeutic areas. The organization prioritizes patient safety and data integrity, ensuring robust methodologies and transparent reporting throughout the research process. By fostering a culture of excellence and collaboration, CMH Jhelum aims to contribute significantly to the global body of medical research and enhance treatment options for patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Jhelum, Punjab, Pakistan
Patients applied
Trial Officials
Muhammad Awais Qarni
Principal Investigator
Anesthesiologist
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials